Kura Oncology, Inc.
Kura Oncology, Inc. (KURA) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 164 transactions totaling $30.4M, demonstrating a bearish sentiment with -$16.9M in net insider flow. The most recent transaction on Jan 27, 2026 involved a sale of 1,311 shares valued at $11.1K.
KURA Insider Activity Summary
Who Is Buying KURA Stock?
No significant insider buying has been recorded for KURA in the recent period.
Who Is Selling KURA Stock?
No significant insider selling has been recorded for KURA in the recent period.
Is Kura Oncology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KURA is bearish with an Insider Alignment Score of 22/100 and a net flow of -$16.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KURA Frequently Asked Questions
Understanding KURA Insider Activity
Insider trading at Kura Oncology, Inc. (KURA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading KURA stock, having executed 164 transactions in the past 90 days. The most active insider is Troy Edward Wilson (Executive), who has made 66 transactions totaling $21.6M.
Related Tools
Track Kura Oncology, Inc. Insider Activity
Get notified when executives and directors at KURA file new Form 4 transactions